EQT Public Value Invests in BioGaia AB

EQT, ADIA and CPP Investments to Acquire QIAGEN

July 9, 2026

Biotechnology

EQT Private Equity, alongside co-investments from the Abu Dhabi Investment Authority through Luxinva and CPP Investments, agreed to acquire QIAGEN in an all-cash public takeover valuing the company at approximately €10.8 billion. The €46.50-per-share offer is subject to shareholder acceptance and regulatory approvals, with completion expected in mid-2027; QIAGEN says private ownership would support long-term investment in innovation, R&D and growth.

EQT Healthcare Growth Agrees to Acquire Majority Stake in Europa Biosite

July 8, 2025

Healthcare Services

EQT Healthcare Growth has agreed to acquire a majority stake in Europa Biosite, a Stockholm-based distributor of research-use-only (RUO) life science reagents and biological substances. The agreement is intended to help Europa Biosite expand biospecimen offerings, strengthen local market presence, enter new regions, and invest in digital infrastructure.

EQT Growth Invests €100M in IntegrityNext

March 23, 2023

Cloud & SaaS

EQT Growth has made a €100 million growth investment in IntegrityNext, a Munich-based cloud SaaS platform for supply chain sustainability and ESG compliance. The capital will support product expansion to meet upcoming European ESG regulations and accelerate IntegrityNext’s international growth; the company will continue to be led by its co-founders.

Equillium Acquires Bioniz Therapeutics

February 16, 2022

Biotechnology

Equillium, Inc. (Nasdaq: EQ) acquired privately held Bioniz Therapeutics, obtaining exclusive worldwide rights to Bioniz's pipeline (BNZ-1, BNZ-2, BNZ-3) and proprietary discovery platform in an all-stock transaction (5,699,492 shares, ~19.3% of Equillium outstanding) plus up to $57.5M in development milestones and up to $250M in sales milestones. The acquisition expands Equillium's immunology capabilities and pipeline, adding complementary clinical-stage cytokine-targeting assets and key research and clinical personnel.

EQT Public Value Takes ~10% Stake in Storytel AB

September 7, 2021

Media & Entertainment

EQT Public Value acquired 6.6 million shares in Storytel AB, representing close to a 10% ownership stake, and has nominated Joakim Rubin to join Storytel's board subject to an extraordinary general meeting. The minority investment is intended for shareholder engagement to support Storytel's next phase of growth in the audiobook and e-book streaming market.

EQT Public Value Takes 2.7% Stake in Securitas AB

September 11, 2020

Professional Services

EQT Public Value, advised by EQT Partners, has acquired 10 million shares in Securitas AB, representing a 2.7% ownership and making it the company's fourth-largest shareholder. The minority investment is intended to support Securitas' ongoing transformation by providing active shareholder engagement and access to EQT's platform capabilities, including digital and sustainability expertise.